This is the authors' abstract. We don't add key points for this paper.
Konstantinos Kotsisa, Paraskevi V Voulgarib, Alexandros A Drososb, André F Carvalhoc & Thomas Hyphantis*aa Department of Psychiatry, Division of Medicine, School of Health Sciences, University of Ioannina, Ioannina 45110, Greeceb Department of Internal Medicine, Rheumatology Clinic, Medical School, University of Ioannina, Greecec Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil*Author for correspondence: +30 265 100 7322 tyfantis@cc.uoi.gr; thomashyphantis@outlook.comAnkylosing spondylitis (AS) is a complex systemic rheumatological disease which often causes severe disability and impaired quality of life (QoL). We searched the PubMed/MEDLINE electronic database for available literature on QoL and its predictors in patients with AS. Recent evidence indicates that AS patients have poorer QoL compared to the general population, but similar to that of patients with other rheumatological disorders. Disease activity is one of the most powerful predictors of QoL, however latest advances in pharmacological treatment (namely, anti-TNF-α) along with physical exercise can minimize the effects of AS on QoL. Psychological distress symptoms contribute to impaired QoL both directly and indirectly by influencing disease activity. The impact of other psychosocial variables, however, is less studied and more prospective investigations are necessary, which could eventually lead to the development of psychosocial interventions that are personalized to this patient population.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kotsis et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: